Evidence map›Paper›PMID 35402526›Full record

ArticleFrontiers in cardiovascular medicine2022

Lithotripsy of Calcified Aortic Valve Leaflets by a Novel Ultrasound Transcatheter-Based Device.

Giacomo Bernava, Enrico Fermi, Guido Gelpi, Stefano Rizzi, Davide Benettin, Marianna Barbuto, Claudia Romagnoni, Domenico Ventrella, Maria Chiara Palmieri, Marco Agrifoglio and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Giacomo BernavaUnità di Ingegneria Tissutale Cardiovascolare, Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
Enrico FermiAorticLab S.r.l., Bioindustry Park, Colleretto Giacosa, Italy.
Guido GelpiASST Fatebenefratelli Sacco, Milan, Italy.
Stefano RizziUnità di Ingegneria Tissutale Cardiovascolare, Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
Davide BenettinAorticLab S.r.l., Bioindustry Park, Colleretto Giacosa, Italy.
Marianna BarbutoUnità di Ingegneria Tissutale Cardiovascolare, Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
Claudia RomagnoniASST Fatebenefratelli Sacco, Milan, Italy.
Domenico VentrellaUniversità Degli Studi di Bologna, Bologna, Italy.
Maria Chiara PalmieriAorticLab S.r.l., Bioindustry Park, Colleretto Giacosa, Italy.
Marco AgrifoglioUniversità Degli Studi di Milano, Milan, Italy.
Gianluca PolvaniUniversità Degli Studi di Milano, Milan, Italy.
Maria Laura BacciUniversità Degli Studi di Bologna, Bologna, Italy.
Enrico PasquinoAorticLab S.r.l., Bioindustry Park, Colleretto Giacosa, Italy.
Maurizio PesceUnità di Ingegneria Tissutale Cardiovascolare, Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
ASST Fatebenefratelli Sacco · ITCentro Cardiologico Monzino · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Bologna · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing incidence of calcific aortic valve disease necessitates the elaboration of new strategies to retard the progression of the pathology with an innovative solution. While the increasing diffusion of the transcatheter aortic valve replacements (TAVRs) allows a mini-invasive approach to aortic valve substitution as an alternative to conventional surgical replacement (SAVR) in an always larger patient population, TAVR implantation still has contraindications for young patients. In addition, it is liable to undergo calcification with the consequent necessity of re-intervention with conventional valve surgery or repeated implantation in the so-called TAVR-in-TAVR procedure. Inspired by applications for non-cardiac pathologies or for vascular decalcification before stenting (i.e., coronary lithotripsy), in the present study, we show the feasibility of human valve treatment with a mini-invasive device tailored to deliver shockwaves to the calcific leaflets. We provide evidence of efficient calcium deposit ruptures in human calcified leaflets treated

Indexed as

calcific aortic valve disease (CAVD)lithotripsy—methodsmedical deviceultrasoundvalve leafletsvalvuloplasty

Identifiers

PMID35402526
PMCPMC8990875
OpenAlexW4226366319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.